BioCentury
ARTICLE | Financial News

Adventrx financial update

August 23, 2010 7:00 AM UTC

Icahn Capital L.P. divested its remaining 3.5 million shares of Adventrx stock during 2Q10. Adventrx, which closed Friday at $1.83 and implemented a 1-for-25 reverse stock split in April, has 14.7 mil...